Premium Nahrungsergänzungsmittel | artgerecht

Incretin Mimetic – Effects, Uses and Side Effects

An incretin mimetic is a medication used to treat type 2 diabetes that mimics the effects of natural gut hormones to regulate blood sugar levels.

Regular tips about health Regular tips about health

Things worth knowing about "Incretin Mimetic"

An incretin mimetic is a medication used to treat type 2 diabetes that mimics the effects of natural gut hormones to regulate blood sugar levels.

What is an Incretin Mimetic?

An incretin mimetic is a class of medications that replicate the effects of naturally occurring gut hormones known as incretins. The most important natural incretins are GLP-1 (Glucagon-like Peptide-1) and GIP (Glucose-dependent Insulinotropic Polypeptide). These hormones are released by the intestine after food intake and play a key role in regulating insulin secretion and blood glucose levels. Incretin mimetics are primarily used to treat type 2 diabetes mellitus.

Mechanism of Action

Incretin mimetics bind to the same receptors as natural incretins and trigger similar physiological effects. The key actions include:

Stimulation of insulin secretion: The pancreas releases more insulin – but only when blood glucose is elevated, which reduces the risk of hypoglycemia (low blood sugar).
Suppression of glucagon release: Glucagon, a hormone that raises blood sugar, is inhibited.
Slowing of gastric emptying: Food stays in the stomach longer, leading to a prolonged feeling of fullness.
Body weight reduction: Enhanced satiety and reduced caloric intake can lead to meaningful weight loss.

Indications

Incretin mimetics are used primarily in the following conditions:

Type 2 diabetes mellitus: To improve blood sugar control, particularly when other medications (e.g., metformin) are insufficient on their own.
Obesity: Some GLP-1 receptor agonists are approved for weight management in patients with significant excess weight.
Cardiovascular risk reduction: Certain incretin mimetics have been shown in clinical studies to reduce the risk of heart attack and stroke in high-risk patients.

Key Active Ingredients

The best-known incretin mimetics belong to the class of GLP-1 receptor agonists. These include:

Semaglutide (e.g., Ozempic, Wegovy) – available as injection or tablet
Liraglutide (e.g., Victoza, Saxenda)
Exenatide (e.g., Byetta, Bydureon)
Dulaglutide (e.g., Trulicity)
Tirzepatide (e.g., Mounjaro) – a dual GIP/GLP-1 receptor agonist

Dosage and Administration

Depending on the specific agent, incretin mimetics are administered either as a subcutaneous injection (under the skin) or as an oral tablet. Dosage depends on the particular medication, the individual treatment goal, and patient tolerability. All treatment decisions should be made by a qualified healthcare provider, with regular monitoring of blood glucose levels.

Side Effects

Like all medications, incretin mimetics can cause side effects. The most common include:

Nausea and vomiting – especially at the start of treatment
Diarrhea or constipation
Abdominal pain
Loss of appetite

Rarer but more serious side effects may include:

Pancreatitis (inflammation of the pancreas)
Kidney impairment
Thyroid tumors (observed in animal studies; clinical relevance in humans is still under investigation)

Patients should consult a doctor immediately if they experience persistent abdominal pain or other unusual symptoms.

Contraindications

Incretin mimetics are not suitable for everyone. They should not be used in:

Type 1 diabetes or diabetic ketoacidosis
Known hypersensitivity to the active ingredient
Severe renal impairment (depending on the specific agent)
Personal or family history of medullary thyroid carcinoma
Pregnancy and breastfeeding (due to insufficient safety data)

References

Nauck MA, Meier JJ. Incretin hormones: Their role in health and disease. Diabetes, Obesity and Metabolism. 2018;20(S1):5–21. doi:10.1111/dom.13129
American Diabetes Association. Standards of Medical Care in Diabetes – 2024. Diabetes Care. 2024;47(Suppl 1):S1–S321.
Drucker DJ. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. Cell Metabolism. 2018;27(4):740–756. doi:10.1016/j.cmet.2018.03.001

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.